M. Heise

Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants

A. Whitmore, T. Sheahan, Damon J. Deming, 2006, PLoS medicine.

Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus

R. Baric, B. Yount, S. Leist, 2024, Nature communications.

Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans

Lisa E. Gralinski, Larissa B. Thackray, Vineet D. Menachery, 2024, Virus research.

U-CAN-seq: A Universal Competition Assay by Nanopore Sequencing

Wes A. Sanders, M. Ferris, M. Heise, 2024, Viruses.

Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants

R. Baric, S. Schendel, S. Dennison, 2023, Journal of virology.

Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse Population

T. A. Bell, R. Baric, Ginger D. Shaw, 2024, Vaccines.

An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus

M. Heise, A. Whitmore, J. Pawęska, 2009, Epidemiology and Infection.

A SARS-CoV-2 peptide vaccine which elicits T-cell responses in mice but does not protect against infection or disease

M. Heise, B. Vincent, A. Rubinsteyn, 2023, bioRxiv.